Enabling The Future
We are committed to research, development & manufacturing of innovative drug products to enhance human life. Our unique product pipeline is designed to combat medical conditions with no mainstream treatment, affecting millions of patients worldwide.
Mild Traumatic Brain Injury (mTBI) is a sudden damage to the brain caused by a blow or jolt to the head. mTBI is increasingly common condition without a medical treatment. It is also our most advanced target condition, with human trials set to begin in 2023.
Amnestic Mild Cognitive Impairment (aMCI) occurs in some patients when the expected cognitive decline of normal aging is accelerated and risks of becoming a more serious case of dementia. It is characterized primarily by problems with memory, and it may become the precursor to Alzheimer's Disease and other neurological conditions. Human trials set to begin in 2023.
Spasticity & Tremors
Multiple sclerosis (MS) is a chronic disease that occurs when the immune system attacks the nerve fibers and myelin sheathing in the brain and the spinal cord. This results in most patients suffering of uncontrollable spasticity and tremors that may cause immense pain, muscle stiffness and involuntary spasms.
Quick Fact Highlights
- mTBI affects 70 million individuals worldwide
- Currently over 5.3 million Americans suffer from the effects of mTBI
- Over 345,000 service members are currently affected by the disease
- 20% of all deployed individuals suffer from mTBI
- Over 20% of individuals over the age of 60 have a form of MCI
- 10% of individuals over the age of 60 will develop Alzheimer’s disease (AD)
- A major risk factor for progression from MCI to AD is emotional distress which is present in up to 85% of all those who have MCI
- Tens of millions of Americans would seek treatment for MCI in the 10 next years
- 2.8 million people worldwide struggle with multiple sclerosis
- MS is the most common central nervous system condition that affects young adults
- MS is a lifelong condition, with no known cure
- Up to 80% of people with MS experience spasticity, and tremors